Epidermolysis Bullosa Simplex
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Epidermolysis Bullosa Simplex

What is the definition of Epidermolysis Bullosa Simplex?
Epidermolysis bullosa simplex (EBS) is one of the major forms of epidermolysis bullosa, a group of genetic conditions that cause the skin to be very fragile and to blister easily. Symptoms of EBS range from mild in the Weber-Cockayne type to severe with blistering that is present at birth or after. Milder phenotypes of EBS have blistering confined to the limbs, whereas in the most severe Dowling Meara type, blisters may also form in the mouth. All of the types are typically caused by genetic changes in the KRT5 and KRT14 genes. They are usually inherited in an autosomal dominant pattern, but autosomal recessive inheritance has occurred in rare cases.
What are the alternative names for Epidermolysis Bullosa Simplex?
  • Epidermolysis bullosa simplex
  • Epidermolysis bullosa intraepidermic
Who are the top Epidermolysis Bullosa Simplex Local Doctors?
Elite in Epidermolysis Bullosa Simplex
Elite in Epidermolysis Bullosa Simplex
Referral may be required
Santiago, RM, CL 

Margarita Calvo practices practicing medicine in Santiago, Chile. Ms. Calvo is rated as an Elite expert by MediFind in the treatment of Epidermolysis Bullosa Simplex. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Epidermolysis Bullosa Simplex, Neuralgia, Epidermolysis Bullosa, and Dystrophic Epidermolysis Bullosa.

Advanced in Epidermolysis Bullosa Simplex
Dermatology
Advanced in Epidermolysis Bullosa Simplex
Dermatology
Referral may be required

MercyOne North Iowa Dermatology Care

1421 4th St. SW, 
Mason City, IA 
Languages Spoken:
English
Accepting New Patients

Dr. Liu became a physician because he always had an interest in medicine and wanted to make a difference in others’ lives. Dr. Liu is rated as an Advanced provider by MediFind in the treatment of Epidermolysis Bullosa Simplex. He is also highly rated in 59 other conditions, according to our data. His clinical expertise encompasses Plaque Psoriasis, Psoriasis, Basal Cell Skin Cancer, and Seborrheic Keratosis. Dr. Liu is board certified in Dermatology, American Board Of Dermatology. Dr. Liu is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Epidermolysis Bullosa Simplex
Advanced in Epidermolysis Bullosa Simplex
Referral may be required

SLUCare Physician Group

1225 S. Grand Blvd., Third Level, 
St. Louis, MO 
Languages Spoken:
English

Dr. Gillian Heinecke treats patients who have skin cancer, psoriasis, eczema, complex medical skin conditions, acne, and warts. Her areas of expertise include psoriasis and dermatopathology. She applies the latest dermatologic advancements in her treatment plans, such as immunosuppressive and biologic therapies. Her research interests include dermatopathology and medical education. Dr. Heinecke is an assistant professor in the Department of Dermatology at Saint Louis University School of Medicine. She is the associate director of the department's residency program. Professional memberships include the American Academy of Dermatology and the American Society of Dermatopathology. Dr. Heinecke is rated as an Advanced provider by MediFind in the treatment of Epidermolysis Bullosa Simplex. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Epidermolysis Bullosa Simplex, Bowen's Disease, Basal Cell Skin Cancer, and Actinic Keratosis. Dr. Heinecke is board certified in American Board Of Dermatology , Drug Enforcement Administration , Illinois Department Of Financial & Professional Regulation , Missouri Dept Of Health/Narcotics&Dangerous Drugs , and Missouri State Board Of Registration.

What are the latest Epidermolysis Bullosa Simplex Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center